Drug Patent Expirations for Sep 28, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

OCTREOSCAN (indium in-111 pentetreotide kit)
Mallinkrodt Nuclear
Patent number: 6,123,916
Expiration Date: Sep 26, 2017

SYMBICORT (budesonide; formoterol fumarate dihydrate)
Astrazeneca
Patent number: 6,123,924
Expiration Date: Sep 26, 2017

CANCIDAS (caspofungin acetate)
Merck
Patent number: 5,952,300
Expiration Date: Sep 28, 2017

CANCIDAS (caspofungin acetate)
Merck
Patent number: 6,136,783
Expiration Date: Sep 28, 2017

BUTRANS (buprenorphine)
Purdue Pharma Lp
Patent number: 9,642,850
Expiration Date: Sep 29, 2017

BUTRANS (buprenorphine)
Purdue Pharma Lp
Patent number: RE 41,571
Expiration Date: Sep 29, 2017

BUTRANS (buprenorphine)
Purdue Pharma Lp
Patent number: RE 41,408
Expiration Date: Sep 29, 2017

BUTRANS (buprenorphine)
Purdue Pharma Lp
Patent number: RE 41,489
Expiration Date: Sep 29, 2017

ZOLPIMIST (zolpidem tartrate)
Magna Pharms
Patent number: 7,632,517
Expiration Date: Oct 1, 2017

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial


This post was originally published on this site
Comments are closed.